<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Danielson Holding Corporation
-----------------------------
(Name of Issuer)
Common Stock, Par Value $.10 per share
--------------------------------------
(Title of Class of Securities)
236274106
----------------
(CUSIP Number)
Alisa M. Singer
Equity Group Investments, L.L.C.
Two North Riverside Plaza, Suite 600
Chicago, Illinois 60606
(312) 454-1800
----------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 12, 1999
--------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
Schedule because of Rule 13d-1 (b)(3) or (4), check the following box [__]
(Page 1 of 9)
Exhibit Index Appears on Page 9
<PAGE>
<TABLE>
<S><C>
CUSIP No. 236274106 13D Page 2 of 9
- ----------------------------------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SZ Investments, L.L.C. FEIN: 36-4150443
- ----------------------------------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- ----------------------------------------------------------------------------------------------------------
3. SEC USE ONLY
- ----------------------------------------------------------------------------------------------------------
4. SOURCE OF FUNDS
WC
- ----------------------------------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [___]
- ----------------------------------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ----------------------------------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 2,000,000
SHARES -------------------------------------------------------------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY
EACH 0
REPORTING -------------------------------------------------------------------------------------------
PERSON 9. SOLE DISPOSITIVE POWER
4,000,000 (1)
-------------------------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
0
- ----------------------------------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,000,000 (1)
- ----------------------------------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES [__]
CERTAIN SHARES
- ----------------------------------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.4% (1)(2)
- ----------------------------------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
OO
- ----------------------------------------------------------------------------------------------------------
(1) Includes 2,000,000 shares which SZ Investments, L.L.C. has the right to
purchase under the warrant described in Item 3. herein, which warrant
is exercisable within 60 days.
(2) Based upon 15,576,276 shares outstanding at May 10, 1999, as reported
in the Issuer's Quarterly Report on Form 10-Q for the quarter ended
March 31, 1999, with the addition of the Initial Shares subsequently
issued to SZ Investments, L.L.C. on August 12, 1999, and assumes the
issuance of an additional 2,000,000 shares upon exercise of the warrant
of SZ Investments, L.L.C.
</TABLE>
<PAGE>
ITEM 1. SECURITY AND ISSUER.
This Statement relates to the common stock, par value $.10 per share
(the "Common Stock"), of Danielson Holding Corporation, a Delaware
corporation (the "Issuer"), which has its principal executive offices at 767
Third Avenue, New York, NY 10017.
ITEM 2. IDENTITY AND BACKGROUND.
(a-c) and (f) This Statement is being filed by SZ Investments,
L.L.C., a Delaware limited liability company ("SZI"). The managing member of
SZI is Zell General Partnership, Inc., an Illinois corporation ("ZGP"). The
sole shareholder of ZGP is Samuel Zell as trustee of the Samuel Zell
Revocable Trust under trust agreement dated January 19, 1990, as amended (the
"Zell Trust"). Additional information concerning SZI, ZGP and Mr. Zell is set
forth in APPENDIX A hereto.
The principal business of SZI and ZGP is general investments. The
business address of each of SZI and ZGP is Two North Riverside Plaza,
Chicago, Illinois 60606.
(d) and (e) Neither SZI nor, to the best knowledge of SZI, ZGP or
any of the persons listed in Appendix A hereto, has during the last five
years (i) been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) or (ii) been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and
as a result of such proceeding was, or is, subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
On August 12, 1999 (the "Closing Date"), pursuant to the Stock
Purchase and Sale Agreement described in Item 4. below, SZI acquired from the
Issuer: (i) 2,000,000 newly issued shares of Common Stock (the "Initial
Shares") and (ii) a warrant to purchase an additional 2,000,000 shares of
Common Stock (the "Warrant", and the shares covered by the Warrant together
with the Initial Shares are sometimes referred to herein as the "Purchased
Shares"). The aggregate amount of funds used in acquiring the Initial Shares
and the Warrant was $9,000,000. All funds used in acquiring the Initial
Shares and the Warrant were obtained from the working capital of SZI.
ITEM 4. PURPOSE OF THE TRANSACTION.
The acquisition of the Initial Shares and the Warrant was effected
for the purpose of investing in the Issuer and to provide funds with which
the Issuer may from time to time fund business acquisitions. In connection
with the transaction, an affiliate of SZI entered into an agreement with the
Issuer to provide certain advisory services to the Issuer and certain of its
subsidiaries in connection with such potential acquisitions.
The Issuer entered into a Stock Purchase and Sale Agreement dated as
of April 14, 1999 (the "Stock Purchase Agreement") with Samstock, L.L.C., a
wholly-owned subsidiary of SZI ("Samstock"). The Stock Purchase Agreement was
amended by Amendment No. 1, Assignment and Consent to Assignment of Stock
Purchase Agreement, dated May 7, 1999 by and among Samstock, the Issuer and
SZI (the "Amendment") pursuant to which the rights and obligations of
Samstock under the Purchase Agreement were assigned to and assumed by SZI. On
the Closing Date, SZI acquired the Initial Shares and the Warrant pursuant to
the Stock Purchase Agreement, as amended. The Stock Purchase Agreement
provided that SZI's obligations thereunder were contingent upon, among other
things, the filing by the Issuer of an amendment to its certificate of
incorporation (i) increasing the number of authorized shares of Common Stock
from 20 million to at least 55 million and (ii) eliminating the right
Page 3 of 9 Pages
<PAGE>
to cumulative voting in connection with the election of directors. On July
20, 1999, a charter amendment satisfying the Issuer's obligations under the
Purchase Agreement and also eliminating the prohibition against the issuance
of non-voting securities was approved at the Issuer's Annual Meeting of
Stockholders and was filed with the State of Delaware. The Stock Purchase
Agreement and the Amendment are attached hereto as Exhibits 1 and 2,
respectively, and are incorporated herein by reference.
In connection with the acquisition of the Initial Shares and the
Warrant, Samstock entered into an Investment Agreement with the Issuer and
Martin J. Whitman, an individual stockholder of the Issuer (the
"Stockholder"). Pursuant to an Assignment and Consent to Assignment of
Investment Agreement dated May 7, 1999, Samstock also assigned to SZI its
rights and obligations under the Investment Agreement. Under the Investment
Agreement, the Issuer and the Stockholder agreed to cause the replacement of
two members of the Issuer's Board of Directors with designees of SZI (as
Samstock's assignee) and to appoint the two designees to a newly-formed
acquisition committee of the Board. SZI will retain the right to designate
two directors, reasonably acceptable to the Issuer, to the Issuer's Board and
the acquisition committee for so long as it owns directly or indirectly at
least 1,000,000 shares of the Issuer's voting securities. SZI selected as its
Board designees Mr. Samuel Zell, President of SZI, and Mr. William C. Pate,
an employee of an affiliate of SZI, and Messrs. Zell and Pate were elected to
the Issuer's Board of Directors at the Issuer's Annual Meeting of
Stockholders on July 20, 1999. Mr. Zell was also elected as the non-executive
Chairman of the Issuer's Board of Directors at a meeting of the Board held
immediately after the Annual Meeting of Stockholders. In addition, so long as
the Stockholder and certain of his affiliated entities own directly or
indirectly an aggregate of at least 500,000 shares of the Issuer's voting
securities, SZI shall vote for the appointment of Stockholder and one
individual designated by Stockholder and reasonably acceptable to SZI to the
Issuer's Board of Directors.
The Investment Agreement also contains certain registration rights
with respect to Common Stock held, from time to time, by SZI. Upon the
earlier of (i) the Issuer's Board approving an acquisition proposal
recommended by the acquisition committee or (ii) the first anniversary of the
Investment Agreement, SZI (or its designee) may make up to two requests that
the Issuer file a shelf registration statement covering the resale of the
Common Stock held from time to time by SZI, subject to certain limitations.
In addition, SZI has piggyback registration rights in connection with a
public offering of Common Stock by the Issuer solely for cash. The Investment
Agreement and the Assignment and Consent to Assignment of Investment
Agreement are attached hereto as Exhibits 3 and 4, respectively, and are
incorporated herein by reference.
Under the terms of the Warrant, SZI has the right, prior to 5:00 p.m.
EST on August 12, 2003, to purchase up to 2,000,000 additional shares of
Common Stock at an exercise price of $4.75 per share. The Warrant also
provides for a cashless exercise by SZI. The number of shares, type of
security, exercise price of the shares of Common Stock covered by the Warrant
are subject to adjustment, in certain events, to prevent dilution. The
exercise date is also subject to adjustment. In addition, the exercise price
will be reduced according to formulas set forth in the Warrant if on the date
of exercise the sum of all losses and expenses paid, and the reserves
maintained by, the Issuer or its subsidiaries for settlement of
asbestos-related claims since December 31, 1998 exceed by more than $5 million
the applicable reserves established by the Issuer's subsidiaries as of
December 31, 1998; provided, however, that the exercise price will not be
reduced below the lower of $3.00 or the current market price of a share of
Common Stock, calculated on a 20-day average of closing prices. The Warrant
will not be subject to the foregoing exercise price adjustment if the Issuer
maintains a policy of reinsurance limiting the amount of asbestos-related
payments (less December 31, 1998 reserves) to $10 million. The Warrant is
attached hereto as Exhibit 5 and is incorporated herein by reference.
The summaries contained in this Scheduled 13D of certain provisions
of each of the Stock Purchase Agreement, Amendment, Investment Agreement,
Assignment and Consent to Assignment of
Page 4 of 9 Pages
<PAGE>
Investment Agreement and Warrant are not intended to be complete and are
qualified in their entirety by reference to each respective agreement
attached as an Exhibit hereto and incorporated herein by reference.
Like all holders of 5% or more of Issuer's Common Stock, SZI will be
subject to restrictions contained in Issuer's Certificate of Incorporation,
which limits stock transfers by 5% or greater shareholders and prohibits
parties from acquiring 5% or more of Issuer's Common Stock without the
Issuer's consent. Subject to the restrictions contained in Issuer's
Certificate of Incorporation, SZI intends to continue to review its
investment in the Common Stock and, from time to time depending upon certain
factors, including without limitation the financial performance of the
Issuer, the availability and price of shares of Common Stock and other
general market and investment conditions, may determine to acquire through
open market purchases or otherwise additional shares of Common Stock, or may
determine to sell through the open market or otherwise, in each case, subject
to the limitations of each of the Stock Purchase Agreement, as amended, and
the Investment Agreement described above.
Except as stated above, neither SZI nor, to the best knowledge of
SZI, any of ZGP or the persons listed in APPENDIX A hereto, has any plans or
proposals of the types referred to in clauses (a) through (j) of Item 4. of
Schedule 13D, as promulgated by the Securities and Exchange Commission.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) and (b) To the best knowledge of SZI, there are 15,576,276 shares of
Common Stock outstanding as of the date hereof.(1) Based upon the foregoing
number, the 2,000,000 Initial Shares beneficially owned by SZI represent
approximately 11.4% of the Common Stock issued and outstanding.(2) The
additional 2,000,000 shares covered by the Warrant represent approximately
10.2% of the Common Stock issued and outstanding,(3) and the aggregate
4,000,000 Purchased Shares represent approximately 20.4% of the Common Stock
issued and outstanding.(2)(3)
SZI currently has the sole power to vote or to direct the vote of
the Initial Shares acquired by it. SZI also has the power to dispose of or to
direct the disposition of its Purchased Shares.
Except as listed below, at the date hereof, neither SZI, nor to the
best knowledge of SZI, any of ZGP or the persons listed in APPENDIX A hereto
owns any shares of Common Stock other than the Purchased Shares owned by SZI,
as described herein. Sheli Rosenberg and Donald Liebentritt own 2,000 and
5,000 shares of Common Stock, respectively. Ms. Rosenberg and Mr. Liebentritt
have the sole power to vote and to dispose of their Common Stock.
(c) During the last sixty days, the only transaction in the Common
Stock effected by SZI, or to the best knowledge of SZI, any of ZGP or the
persons listed in APPENDIX A hereto, was the transaction that occurred on
August 12, 1999, as described herein.
(d) No person other than SZI has the right to receive or the power
to direct the receipt of dividends from, or the proceeds from the sale of the
shares of Common Stock owned by SZI.
(e) Not applicable.
- -------------------------
(1) As disclosed in the Issuer's Quarterly Report on Form 10-Q for the quarter
ended March 31, 1999.
(2) Based upon 15,576,276 shares of Common Stock outstanding with the addition
of the Initial Shares issued on August 12, 1999.
(3) On a fully-diluted bases with respect only to the number of shares covered
by the Warrant.
Page 5 of 9 Pages
<PAGE>
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR
RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.
Except for the matters described herein, neither SZI nor, to the
best knowledge of SZI, any of ZGP or the persons listed in APPENDIX A hereto
has any contract, arrangement, understanding or relationship with any person
with respect to any securities of the Issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1 - Stock Purchase and Sale Agreement
(incorporated by reference to Exhibit 10.1
of Danielson Holding Corporation's Quarterly
Report on Form 10-Q for the quarter ended
June 30, 1999, filed with the Securities and
Exchange Commission on August 13, 1999)
Exhibit 2 - Amendment No. 1, Assignment and Consent to
Assignment of Stock Purchase Agreement
(incorporated by reference to Exhibit 10.2
of Danielson Holding Corporation's Quarterly
Report on Form 10-Q for the quarter ended
June 30, 1999, filed with the Securities and
Exchange Commission on August 13, 1999)
Exhibit 3 - Investment Agreement (incorporated by
reference to Exhibit 10.3 of Danielson
Holding Corporation's Quarterly Report on
Form 10-Q for the quarter ended June 30,
1999, filed with the Securities and Exchange
Commission on August 13, 1999)
Exhibit 4 - Assignment and Consent to Assignment of
Investment Agreement (incorporated by
reference to Exhibit 10.4 of Danielson
Holding Corporation's Quarterly Report on
Form 10-Q for the quarter ended June 30,
1999, filed with the Securities and Exchange
Commission on August 13, 1999)
Exhibit 5 - Warrant (filed herewith)
Page 6 of 9 Pages
<PAGE>
APPENDIX A
SCHEDULE 13D
CUSIP NUMBER 236274106
The following persons are executive officers of each of SZI and ZGP,
holding the same offices for each such entity:
Samuel Zell is President of the entities and is also chairman of
Equity Group Investments, L.L.C. ("EGI").
Rod Dammeyer is a Vice President of the entities and is also Managing
Director-Corporate Investments of EGI.
Sheli Z. Rosenberg is a Vice President of the entities and is also the
President and Chief Executive Officer of EGI.
Donald J. Liebentritt is a Vice President of the entities and is also
the Chief Operating Officer and General Counsel of EGI.
The business address of each of the executive officers is Two North Riverside
Plaza, Chicago, Illinois 60606, and each is a citizen of the United States of
America.
Page 7 of 9 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of the undersigned's
knowledge and belief, the undersigned certify that the information set forth
in the statement is true, complete and correct.
DATED: August 20, 1999
SZ INVESTMENTS, L.L.C.
By: /s/ Donald J. Liebentritt
-------------------------
Name: Donald J. Liebentritt
Title: Vice President
Page 8 of 9 Pages
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Number Description
- -------------- -----------
<S> <C>
1 Stock Purchase and Sale Agreement (incorporated by
reference to Exhibit 10.1 of Danielson Holding
Corporation's Quarterly Report on Form 10-Q for the
quarter ended June 30, 1999, filed with the
Securities and Exchange Commission on August 13,
1999)
2 Amendment No. 1, Assignment and Consent to Assignment
of Stock Purchase Agreement (incorporated by
reference to Exhibit 10.2 of Danielson Holding
Corporation's Quarterly Report on Form 10-Q for the
quarter ended June 30, 1999, filed with the
Securities and Exchange Commission on August 13,
1999)
3 Investment Agreement (incorporated by reference to
Exhibit 10.3 of Danielson Holding Corporation's
Quarterly Report on Form 10-Q for the quarter ended
June 30, 1999, filed with the Securities and Exchange
Commission on August 13, 1999)
4 Assignment and Consent to Assignment of Investment
Agreement (incorporated by reference to Exhibit 10.4
of Danielson Holding Corporation's Quarterly Report
on Form 10-Q for the quarter ended June 30, 1999,
filed with the Securities and Exchange Commission on
August 13, 1999)
5 Warrant*
</TABLE>
- ------------------------------------
* Filed herewith.
Page 9 of 9 Pages
<PAGE>
Stock Warrant No. 1
THIS WARRANT AND THE SECURITIES THAT MAY BE ACQUIRED UPON THE EXERCISE OF
THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR ANY STATE SECURITIES ACT AND MAY NOT BE SOLD OR TRANSFERRED IN
THE ABSENCE OF REGISTRATION OR EXEMPTION THEREFROM OR AS OTHERWISE PROVIDED
IN THIS WARRANT.
THE EXERCISE OF THIS WARRANT MAY BE SUBJECT TO THE FILING OF A NOTIFICATION
REPORT UNDER THE HART-SCOTT-RODINO ANTITRUST IMPROVEMENTS ACT OF 1976, AS
AMENDED, AND THE EXPIRATION OF OR TERMINATION OF THE APPLICABLE WAITING
PERIOD THEREUNDER.
DANIELSON HOLDING CORPORATION
Common Stock Warrant
Danielson Holding Corporation, a Delaware corporation (the
"Company"), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, SZ Investments,
L.L.C., a Delaware limited liability company ("SZ"), or its permitted assigns
under the terms of this warrant (SZ or such permitted assigns at the time
being the registered holder or holders hereof being hereinafter referred to
as "Holder") is entitled, subject to the terms set forth below, to purchase
from the Company, at a purchase price per share of $4.75 (as such amount may
be adjusted from time to time pursuant to Sections 1.5 or 3 hereof, the
"Purchase Price"), at any time or from time to time prior to 5:00 p.m.,
Eastern Standard Time, on the Expiration Date, 2,000,000 fully paid and
non-assessable shares of Common Stock, $.10 par value per share, of the
Company (the "Common Stock") (such shares of Common Stock as the number and
characterization of such shares may be adjusted or otherwise modified from
time to time pursuant to Sections 3 or 4, are herein referred to as the
"Warrant Shares").
Certain capitalized terms not otherwise defined herein shall have
the meanings set forth in Section 6 hereof.
SECTION 1 EXERCISE OF WARRANT.
1.1 EXERCISE. This Warrant may be exercised by Holder, in whole
or in part (but not for less than 100,000, subject to pro rata adjustment for
any subdivision of Common Stock or the payment of any dividend in shares of
Common Stock, of the Warrant Shares issuable under this Warrant, or the
remaining Warrant Shares, if less than such amount), at any time and from
time to time prior to 5:00 p.m., Eastern Standard Time, on the Expiration
Date, by surrender of this Warrant, together with a subscription
substantially in the form of Exhibit A attached to this Warrant (or a
reasonable facsimile thereof) duly executed by Holder, to the Company at its
principal office and accompanied by payment in full, in cash or by check
payable to the order of the Company (or in the manner provided in Section 1.2
hereof), in the amount of the aggregate Purchase Price for the Warrant Shares
covered by such exercise.
<PAGE>
1.2 CASHLESS EXERCISE. In lieu of exercising this Warrant
pursuant to Section 1.1 above, the Holder shall have the right at any time
and from time to time prior to 5:00 p.m., Eastern Standard Time, on the
Expiration Date to exercise this Warrant, in whole or in part, by requiring
the Company to convert all or any part of this Warrant (the "Conversion
Right"), into Warrant Shares by surrendering this Warrant to the Company
accompanied by the form conversion notice (substantially in the form attached
hereto as Exhibit B, or a reasonable facsimile thereof) which has been duly
completed and signed. Upon exercise of the Conversion Right, the Company
shall deliver to the Holder (without payment by the Holder of any cash in
respect of the Purchase Price) that number of Warrant Shares which is equal
to the amount obtained by dividing (x) an amount equal to the difference
between (A) the Current Market Price Per Share multiplied by the number of
Warrant Shares as to which the Conversion Right is then being exercised (the
"Conversion Shares"), determined as of immediately prior to the effective
time of the exercise of the Conversion Right, minus (B) the aggregate
Purchase Price then applicable to the Conversion Shares (such difference, the
"Conversion Amount"), by (y) the Current Market Price Per Share of one share
of Common Stock determined as of immediately prior to the effective time of
the exercise of the Conversion Right. Upon exercise of the Conversion Right,
the Conversion Amount shall be deemed to have been paid to the Company in
respect of the Warrant Shares so acquired. Any references in this Warrant to
the "exercise" of this Warrant, and the use of the term "exercise" herein,
shall be deemed to include, without limitation, any exercise of the
Conversion Right. In the event this Warrant is not exercised in full, the
Warrant Shares shall be reduced by the number of Warrant Shares subject to
such partial exercise, and the Company, at its expense, shall forthwith issue
and deliver to Holder a new Warrant of like tenor in the name of Holder,
reflecting such adjusted Warrant Shares.
1.3 WHEN EXERCISE EFFECTIVE. Each exercise of this Warrant
shall be deemed to have been effected immediately prior to the close of
business on the Business Day on which this Warrant (together with the
applicable subscription and Purchase Price) shall have been surrendered to
the Company as provided in Section 1.1 or 1.2 hereof, and at such time the
Person or Persons in whose name or names any certificate or certificates for
shares of Common Stock (or Other Securities) shall be issuable upon such
exercise as provided in Section 1.4 shall be deemed to have become the holder
or holders of record thereof. The warrant or warrants surrendered upon
exercise thereof shall thereafter be canceled and of no further force or
effect.
1.4 DELIVERY OF STOCK CERTIFICATES, ETC. As soon as practicable
after each exercise of this Warrant, in whole or in part, the Company at its
expense (including the payment by it of any and all applicable issue taxes
but excluding any applicable transfer taxes) will issue and deliver to
Holder: (a) a certificate or certificates (or an escrow receipt in lieu
thereof as may be required under Section 5.2 of the Company's Certificate of
Incorporation), in such name or names as such Holder may designate, for the
number of duly authorized, validly issued, fully paid and non-assessable
shares of Common Stock to which Holder shall be entitled on such exercise,
plus, in lieu of any fractional share to which such holder would otherwise be
entitled, cash in an amount equal to the same fraction of the Current Market
Price Per Share determined as of the Business Day preceding the date of such
exercise, and (b) in case such exercise is for less than all the Warrant
Shares issuable hereunder, a new Warrant representing such Warrant or
Warrants remaining hereunder in substantially the form of this Warrant.
2
<PAGE>
1.5 REDUCTION OF PURCHASE PRICE FOR A&E DEFICIENCY. If on the
date of any exercise pursuant to Section 1.1 or 1.2 above (determined in
accordance with Section 1.3 hereof) the Company does not have in effect an
Excess of Loss Policy and there exists an A&E Deficiency, then the Purchase
Price applicable to such exercise shall be automatically reduced as follows
(the "Price Reduction"):
(a) If the A&E Deficiency is:
(i) greater than $5,000,000 but less than or
equal to $10,000,000, the Purchase Price shall be reduced by an amount
determined by dividing (x) 40.8% of the amount by which the A&E
Deficiency exceeds $5,000,000, by (y) the initial number of Warrant
Shares represented by the original Warrant (taking into account any
adjustment pursuant to Sections 3 and 4 hereof);
(ii) greater than $10,000,000, the Purchase Price
shall be reduced by an amount determined by dividing (x) an amount
equal to the sum of (A) 20.4% of the amount by which the A&E
Deficiency exceeds $10,000,000 plus (B) $2,040,000 by (y) the initial
number of Warrant Shares represented by the original Warrant (taking
into account any adjustment pursuant to Sections 3 and 4 hereof);
(b) If the Holder has previously exercised a portion of the
Warrant, then the Purchase Price shall, in addition to any reduction pursuant
to subsection (a) above, be further reduced by an amount determined by
dividing (x) the excess, if any, of (A) the Price Reduction calculated
pursuant to subsection (a) above multiplied by the aggregate number of
Warrant Shares issued upon all prior exercises of the Warrant over (B) the
Aggregate Price Reduction, by (y) the total number of Warrant Shares to which
the current exercise relates.
(c) Notwithstanding the foregoing, the Price Reduction shall be
applied only to the extent that it does not cause the Purchase Price to be
reduced below the lower of (x) $3.00, which amount shall be adjusted
proportionately with any adjustment in the Purchase Price pursuant to Section
3 hereof, or (y) the Current Market Price Per Share as of the date of such
adjustment.
(d) The Price Reduction is independent of and in addition to
any adjustment required by Section 3 hereof, is applicable only to the
particular exercise to which such Price Reduction relates and shall not
affect any future calculations except to the extent that a Price Reduction
increases Aggregate Price Reduction.
3
<PAGE>
SECTION 2 CERTAIN OBLIGATIONS OF THE COMPANY.
2.1 RESERVATION OF STOCK. The Company covenants that it will at
all times reserve and keep available, free from preemptive rights, solely for
issuance and delivery upon exercise of this Warrant, the number of shares of
Common Stock (or Other Securities) from time to time issuable upon exercise
of this Warrant. In furtherance of and not in limitation of the foregoing,
the Company will from time to time, in accordance with the laws of its state
of incorporation, take all necessary action to increase and maintain the
authorized amount of its Common Stock (or Other Securities) if at any time
the number of shares of Common Stock authorized but remaining unissued and
unreserved for other purposes shall be insufficient to permit the full
exercise of this Warrant.
2.2 STATUS OF WARRANT SHARES; CORPORATE ACTIONS. The Company
covenants that all Warrant Shares, upon issuance in accordance with the terms
of this Warrant Agreement and the Company's Certificate of Incorporation, as
amended from time to time (the "Certificate of Incorporation"), shall be
fully paid and nonassessable and free from all taxes with respect to the
issuance thereof (other than income taxes, if any, related to ordinary income
attributable to the Holder) and from all liens, charges and security
interests other than transfer restrictions contained in the Company's
Certificate of Incorporation. The Company will not, by amendment of its
Certificate of Incorporation or through any consolidation, merger,
reorganization, transfer of assets, dissolution, issuance or sale of
securities or any other voluntary action or omission, avoid or seek to avoid
the observance or performance of any of the terms of this Warrant. Without
limiting the generality of the foregoing, the Company (a) will not permit the
par value or the determined or stated value of any shares of the Common Stock
receivable upon the exercise of this Warrant to exceed the amount payable
therefor upon such exercise and (b) will take all such action as may be
necessary or appropriate in order that the Company may validly and legally
issue fully paid and nonassessable shares of the Common Stock (or Other
Securities) upon the exercise of this Warrant, including, without limitation,
amending the Certificate of Incorporation.
2.3 MAINTENANCE OF OFFICE. The Company will maintain an office
where presentations and demands to or upon the Company in respect of this
Warrant may be made. The initial location of such office shall be at 767
Third Avenue, New York, NY 10017. The Company will give notice in writing to
Holder in accordance with Section 11 hereof of each change in the location of
such office.
2.4 USE OF PROCEEDS. The Company agrees that proceeds paid to
the Company from any Holder's exercise of the Warrant shall be retained as
direct assets of the Company and such proceeds shall not be transferred or
attributed in any way, directly or indirectly, to any insurance subsidiary of
the Company.
4
<PAGE>
SECTION 3 ADJUSTMENT OF PURCHASE PRICE.
3.1 GENERAL; PURCHASE PRICE. The number of shares of Common
Stock which the holder of this Warrant shall be entitled to receive upon each
exercise hereof shall be determined by multiplying the number of shares of
Common Stock which would otherwise (but for the provisions of this Section 3)
be issuable upon such exercise, as designated by the holder hereof pursuant
to Section 1 hereof, by the fraction of which (a) the numerator is $4.75, and
(b) the denominator is the Purchase Price in effect on the date of such
exercise. The "Purchase Price" shall initially be $4.75 per share, shall be
adjusted and readjusted from time to time as provided in this Section 3 and,
as so adjusted or readjusted, shall remain in effect until a further
adjustment or readjustment thereof is required by this Section 3.
3.2. ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. In case the
Company at any time or from time to time after the date hereof shall issue or
sell Additional Shares of Common Stock (including Additional Shares of Common
Stock deemed to be issued pursuant to Section 3.3 or 3.4 hereof) without
consideration or for a consideration per share less than the Purchase Price
in effect immediately prior to such issue or sale, then, and in each such
case, such Purchase Price shall be reduced, concurrently with such issue or
sale, to a price (calculated to the nearest .001 of a cent) determined by
multiplying such Purchase Price by a fraction,
(i) the numerator of which shall be (A) the
number of shares of Common Stock outstanding immediately
prior to such issue or sale plus (B) the number of shares of
Common Stock which the aggregate consideration received by
the Company for the total number of such Additional Shares of
Common Stock so issued or sold would purchase at the Purchase
Price in effect immediately prior to such sale; and
(ii) the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such
issue or sale, provided that, for the purposes of this Section
3.2, (A) immediately after any Additional Shares of Common
Stock are deemed to have been issued pursuant to Section 3.3
or 3.4 hereof, such Additional Shares of Common Stock shall be
deemed to be outstanding, and (B) treasury shares shall not be
deemed to be outstanding.
3.3. TREATMENT OF OPTIONS AND CONVERTIBLE SECURITIES. In case
the Company at any time or from time to time after the date hereof shall
issue, sell, grant or assume, or shall fix a record date for the
determination of holders of any class of securities entitled to receive, any
Options or Convertible Securities, then, and in each such case, the maximum
number of Additional Shares of Common Stock (as set forth in the instrument
relating thereto, without regard to any provisions contained therein for a
subsequent adjustment of such number) issuable upon the exercise of such
Options or, in the case of Convertible Securities and options therefor,
issuable upon the conversion or exchange of such Convertible Securities,
shall be deemed to be Additional Shares of Common Stock issued as of the time
of such issue, sale, grant or assumption or, in case such a record date shall
have been fixed, as of the close of business on such record date (or, if the
Common Stock trades on an ex-dividend basis, on the date prior to the
commencement of ex-dividend trading); provided that such Additional Shares of
Common Stock shall not be deemed to have been issued unless the consideration
per share (determined pursuant to Section 3.5 hereof) of such shares would be
less than the Purchase Price in effect on the date of and immediately prior
to such issue, sale, grant or assumption or
5
<PAGE>
immediately prior to the close of business on such record date (or, if the
Common Stock trades on an ex-dividend basis, on the date prior to the
commencement of ex-dividend trading), as the case may be; and, provided,
further, that in any such case in which Additional Shares of Common Stock are
deemed to be issued:
(a) no further adjustment of the Purchase Price shall
be made upon the subsequent issue or sale of Convertible Securities or shares
of Common Stock upon the exercise of such Options or the conversion or
exchange of such Convertible Securities, except in the case of any such
Options or Convertible Securities which contain provisions requiring an
adjustment, subsequent to the date of the issue or sale thereof, of the
number of Additional Shares of Common Stock issuable upon the exercise of
such Options or the conversion or exchange of such Convertible Securities by
reason of (i) a change of control of the Company or (ii) the acquisition by
any Person or group of Persons of any specified number or percentage of the
Voting Securities of the Company;
(b) if such Options or Convertible Securities by their
terms provide, with the passage of time or otherwise, for any increase in the
consideration payable to the Company, or decrease in the number of Additional
Shares of Common Stock issuable, upon the exercise, conversion or exchange
thereof (by change of rate or otherwise), the Purchase Price computed upon
the original issue, sale, grant or assumption thereof (or upon the occurrence
of the record date, or date prior to the commencement of ex-dividend trading,
as the case may be, with respect thereto), and any subsequent adjustments
based thereon, shall, upon any such increase or decrease becoming effective,
be recomputed to reflect such increase or decrease insofar as it affects such
options, or the rights of conversion or exchange under such Convertible
Securities, which are outstanding at such time;
(c) upon the expiration (or purchase by the Company
and cancellation or retirement) of any such Options which shall not have been
exercised or the expiration of any rights of conversion or exchange under any
such Convertible Securities which (or purchase by the Company and
cancellation or retirement of any such Convertible Securities the rights of
conversion or exchange under which) shall not have been exercised, the
Purchase Price computed upon the original issue, sale, grant or assumption
thereof (or upon the occurrence of the record date, or date prior to the
commencement of ex-dividend trading, as the case may be, with respect
thereto), and any subsequent adjustments based thereon, shall, upon such
expiration (or such cancellation or retirement, as the case may be), be
recomputed as if:
(i) in the case of Options for Common Stock or
Convertible Securities, the only Additional Shares of Common Stock
issued or sold were the Additional Shares of Common Stock, if any,
actually issued or sold upon the exercise of such Options or the
conversion or exchange of such Convertible Securities and the
consideration received therefor was the consideration actually received
by the Company for the issue, sale, grant or assumption of all such
Options, whether or not exercised, plus the consideration actually
received by the Company upon such exercise, or for the issue or sale of
all such Convertible Securities which were actually converted or
exchanged, plus the additional consideration, if any, actually received
by the Company upon such conversion or exchange; and
(ii) in the case of Options for Convertible Securities,
only the Convertible Securities, if any, actually issued or sold upon
the exercise of such Options were issued
6
<PAGE>
at the time of the issue, sale, grant or assumption of such Options,
and the consideration received by the Company for the Additional
Shares of Common Stock deemed to have then been issued was the
consideration actually received by the Company for the issue, sale,
grant or assumption of all such Options, whether or not exercised,
plus the consideration deemed to have been received by the Company
(pursuant to Section 3.5 hereof) upon the issue or sale of such
Convertible Securities with respect to which such Options were
actually exercised;
(d) no readjustment pursuant to subdivision (b) or (c)
above shall have the effect of increasing the Purchase Price by an amount in
excess of the amount of the adjustment thereof originally made in respect of
the issue, sale, grant or assumption of such Options or Convertible
Securities; and
(e) in the case of any such Options which expire by
their terms not more than 30 days after the date of issue, sale, grant or
assumption thereof, no adjustment of the Purchase Price shall be made until
the expiration or exercise of all such Options, whereupon such adjustment
shall be made in the manner provided in subdivision (c) above.
3.4. TREATMENT OF STOCK DIVIDENDS, STOCK SPLITS, ETC. In case
the Company at any time or from time to time after the date hereof shall
declare or pay any dividend on the Common Stock payable in Common Stock, or
shall effect a subdivision of the outstanding shares of Common Stock into a
greater number of shares of Common Stock (by reclassification or otherwise
than by payment of a dividend in Common Stock), then, and in each such case,
with respect to any adjustment of the Purchase Price pursuant to Section 3.2,
Additional Shares of Common Stock shall be deemed to have been issued (a) in
the case of any such dividend, immediately after the close of business on the
record date for the determination of holders of any class of securities
entitled to receive such dividend, or (b) in the case of any such
subdivision, at the close of business on the day immediately prior to the day
upon which such corporate action becomes effective.
3.5 COMPUTATION OF CONSIDERATION. For the purposes of this
Section 3:
(a) the consideration for the issue or sale of any
Additional Shares of Common Stock shall, irrespective of the accounting
treatment of such consideration,
(i) insofar as it consists of cash, be computed
at the net amount of cash received by the Company, (without
deducting any expenses paid or incurred by the Company or any
commissions or compensations paid or concessions or discounts
allowed to underwriters, dealers or others performing similar
services in connection with such issue or sale);
(ii) insofar as it consists of property
(including securities) other than cash, be computed at the
fair value thereof at the time of such issue or sale, as
determined in good faith by the Board of Directors of the
Company; and
(iii) in case Additional Shares of Common Stock
are issued or sold together with other stock or securities or
other assets of the Company for a consideration which covers
both, be the portion of such consideration so received,
computed as provided in clauses (i) and (ii) above, allocable
to such
7
<PAGE>
Additional Shares of Common Stock, all as determined
in good faith by the Board of Directors of the Company.
(b) Additional Shares of Common Stock deemed to have
been issued pursuant to Section 3.3, relating to Options and Convertible
Securities, shall be deemed to have been issued for a consideration per share
determined by dividing
(i) the total amount, if any, received and
receivable by the Company as consideration for the issue,
sale, grant or assumption of the Options or Convertible
Securities in question plus the aggregate amount of
additional consideration (as set forth in the instruments
relating thereto, without regard to any provision contained
therein for a subsequent adjustment of such consideration to
protect against dilution) payable to the Company upon the
exercise in full of such Options or the conversion or
exchange of such Convertible Securities or, in the case of
Options for Convertible Securities, the exercise of such
options for Convertible Securities and the conversion or
exchange of such Convertible Securities, in each case
computing such consideration as provided in the foregoing
subdivision (a), by
(ii) the maximum number of shares of Common Stock
(as set forth in the instruments relating thereto, without
regard to any provision contained therein for a subsequent
adjustment of such number to protect against dilution)
issuable upon the exercise of such Options or the conversion
or exchange of such Convertible Securities.
(c) Additional Shares of Common Stock deemed to have been
issued pursuant to Section 3.4 hereof, relating to stock dividends, stock
splits, etc., shall be deemed to have been issued for no consideration,
unless and only to the extent that consideration is actually paid therefor.
3.6. ADJUSTMENTS FOR COMBINATIONS, ETC. In case the outstanding
shares of Common Stock shall be combined or consolidated, by reclassification
or otherwise, into a lesser number of shares of Common Stock, the Purchase
Price in effect immediately prior to such combination or consolidation shall,
concurrently with the effectiveness of such combination or consolidation, be
proportionately increased.
SECTION 4 RECLASSIFICATION, CONSOLIDATION, MERGER, ETC. In the case
of (A) any capital reorganization, reclassification or other change of
outstanding Common Stock (or Other Securities) (other than those referred to
in Section 3.4 hereof and other than a change in par value), or (B) any
consolidation of the Company with any other corporation or any merger of the
Company into another corporation or of another corporation into the Company
(other than a consolidation or merger in which the Company is the continuing
or surviving corporation and which does not result in any reclassification
of, or change (other than a change in par value, or as a result of a
subdivision or combination to which Section 3.4 hereof is applicable) in, the
outstanding Common Stock (or Other Securities)), or (C) any sale or transfer
to another Person (other than by mortgage or pledge) of all or substantially
all of the properties and assets of the Company, each Warrant shall from and
after such event or transaction be exercisable upon the terms and conditions
specified in this Warrant, for the number of shares of stock or other
securities or assets to which the Holder (at the time of the transaction or
event) upon
8
<PAGE>
exercise of this Warrant would have been entitled upon such transaction or
event as if such Holder exercised this Warrant in full immediately prior to
such transaction or event and in any such case, if necessary, the provisions
set forth in this Section 4 with respect to the rights thereafter of the
Holder shall be appropriately adjusted so as to be applicable, as nearly as
may be possible, to any shares of stock or other securities or assets
thereafter deliverable on the exercise of the Warrant; provided, that any
such resulting or surviving corporation or purchaser, as the case may be, in
any such transaction, shall expressly assume, by delivery of a written
instrument delivered to the Company and the Holder prior to consummation of
the transaction in question, the obligation to deliver, upon the exercise of
the Warrant, such shares, securities or property as the Holder of the Warrant
or other securities received by the Holder in place thereof, shall be
entitled to receive pursuant to the provisions hereof, and to make provisions
for the protection of the exercise rights as above provided.
SECTION 5 NOTICE OF CERTAIN EVENTS.
If at any time:
(a) the Company shall declare any dividend or distribution
payable to the holders of its Common Stock (whether payable in cash, Common
Stock or other consideration);
(b) the Company shall offer for subscription or issuance pro
rata to the holders of its Common Stock any additional shares of stock of any
class;
(c) there shall be any capital reorganization of the Company,
any recapitalization or reclassification of the capital stock of the Company,
or consolidation or merger involving the Company, or any sale or transfer of
all or substantially all of the Company's assets to any other Person;
(d) there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Company as a whole or substantially as a
whole in a single transaction or a series of related transactions; or
(e) there shall be any other event which would or may require
adjustment of at least 1% of the Purchase Price or the Warrant Shares
pursuant to Section 3 or 4 hereof,
then, in any one or more of such cases, the Company shall give Holder written
notice of the date on which a record shall be taken for such dividend,
distribution or subscription rights or for determining stockholders entitled
to vote upon such reorganization, recapitalization, reclassification,
consolidation, merger, sale, transfer, dissolution, liquidation or winding up
and of the date, if determined, when any such transaction shall take place,
as the case may be. If and to the extent applicable, such notice shall also
specify the date as of which the holders of Common Stock of record shall
participate in such dividend, distribution or subscription rights or shall be
entitled to exchange their Common Stock for securities or other property
deliverable upon such recapitalization, consolidation, merger, sale,
dissolution, liquidation or winding up, as the case may be. Such notice shall
be given at least 30 days before the earliest date required to be specified
therein in accordance with this subparagraph, shall describe the proposed
transaction in reasonable detail and shall specify the consideration to be
received by the holders of Common Stock in respect thereto and/or any
adjustment which would be made to the number of Warrant Shares obtainable
upon the exercise of this Warrant as a result of such
9
<PAGE>
transaction; PROVIDED, HOWEVER, that the Company shall be obligated to give
only ten 10 days prior notice with respect to the following events: (i) any
event the occurrence of which would give rise to an adjustment pursuant to
the provisions of Section 3 or (ii) any regularly-scheduled dividend or
distribution which, individually or as a policy, has been previously publicly
announced. The Company shall also furnish to each Holder all notices and
materials furnished to its stockholders in connection with such transaction
as and when such notices and materials are furnished to its stockholders.
SECTION 6 DEFINITIONS.
As used herein, the following terms, unless the context otherwise
requires, have the following respective meanings:
6.1 The term "ADDITIONAL SHARES OF COMMON STOCK" shall mean all
shares (including treasury shares) of Common Stock issued or sold (or,
pursuant to Section 3.3 or 3.4 hereof, deemed to be issued) by the Company
after the date hereof, whether or not subsequently reacquired or retired by
the Company, other than: (a) shares issued upon the exercise of this Warrant;
(b) options and shares issued upon the exercise of options outstanding on the
date hereof or to be granted under any Company stock option plan or stock
purchase plan as in effect on the date hereof or under any other employee or
director stock option or purchase plan or plans adopted or assumed after such
date and which have been duly approved and adopted by a vote of the
stockholders of the Company; (c) such additional number of shares as may
become issuable upon the exercise of any of the securities referred to in the
foregoing clauses (a) or (b), by reason of adjustments required pursuant to
anti-dilution provisions applicable to such securities as in effect on the
date hereof, but only if and to the extent that such adjustments are required
as the result of the original issuance of the Warrants; (d) such additional
number of shares as may become issuable upon the exercise of any of the
securities referred to in the foregoing clauses (a), (b), or (c) by reason of
adjustments required pursuant to anti-dilution provisions applicable to such
securities as in effect on the date hereof, in order to reflect any
subdivision or combination of Common Stock, by reclassification or otherwise,
or any dividend on Common Stock payable in Common Stock.
6.2 The term "A&E DEFICIENCY" shall mean the amount by which
the sum of losses and loss adjustment expenses actually paid by the insurance
company subsidiaries of the Company in settlement of asbestos-related claims
and environmental-related claims between December 31, 1998, and the date of
exercise of the Warrant, plus the reserves for such losses and loss
adjustment expenses as of such exercise date, exceed the reserves established
by such subsidiaries for such losses and loss adjustment expenses (including
reserves for losses that have been incurred but which have not been reported)
as of December 31, 1998.
6.3 The term "AGGREGATE PRICE REDUCTION" means the sum of all
reductions from the aggregate purchase price paid in connection with all
prior exercises, calculated in accordance with Section 1.5 hereof; provided
that for purposes of determining this amount, such reductions for cashless
exercises pursuant to Section 1.2 hereof shall be determined by multiplying
the number of Warrant Shares as to which the Conversion Right is then being
exercised by the Price Reduction applicable to such cashless exercise.
10
<PAGE>
6.4 The term "BUSINESS DAY" means any day other than a Saturday
or a Sunday or a day on which commercial banking institutions in New York
City are authorized by law to be closed. Any reference to "days" (unless
Business Days are specified) shall mean calendar days.
6.5 The term "CHARTER AMENDMENT" shall have the meaning
ascribed to it in the Purchase and Sale Agreement.
6.6 The term "COMMON STOCK" shall have the meaning ascribed to
it in the introductory paragraph to this Warrant, provided that such term
shall also include any other securities or rights into which or for which the
Common Stock is converted or exchanged, whether pursuant to a plan of
reclassification, reorganization, consolidation, merger, sale of assets,
dissolution, liquidation, or otherwise.
6.7 The term "CONVERTIBLE SECURITIES" shall mean any evidence
of indebtedness, shares of stock (other than Common Stock) or other
securities directly or indirectly convertible into or exchangeable for
Additional Shares of Common Stock.
6.8 The term "CURRENT MARKET PRICE PER SHARE" shall mean, with
respect to any of the Common Stock, as of any particular date of
determination, the average of the daily closing prices of the Common Stock as
reported in THE WALL STREET JOURNAL or other reputable financial news source,
for the 20 consecutive trading days immediately preceding such date.
6.9 The term "EXCESS OF LOSS POLICY" shall mean a policy of
reinsurance obtained by the insurance company subsidiaries of the Company,
which reinsurance policy shall limit the amount of the A&E Deficiency payable
by such insurance company subsidiaries to $10,000,000.
6.10 The term "EXPIRATION DATE" shall mean 5:00 p.m., Eastern
Standard Time, on August 12, 2003; provided however that if on such date the
Purchase Price would be subject to adjustment pursuant to Section 1.5 herein
if the Warrant were then exercised, then the Expiration Date shall be
extended until August 12, 2004.
6.11 The term "OPTIONS" shall mean any and all rights, options
or warrants to subscribe for, purchase or otherwise acquire either Additional
Shares of Common Stock or Convertible Securities.
6.12 The term "OTHER SECURITIES" shall mean any stock (other
than Common Stock) and other securities of the Company or any other Person
(corporate or otherwise) which the holders of this Warrant at any time shall
be entitled to receive, or shall have received, upon the exercise of this
Warrant, in lieu of or in addition to Common Stock, or which at any time
shall be issuable or shall have been issued in exchange for or in replacement
of Common Stock or Other Securities pursuant to Section 4 hereof or otherwise.
6.13 The term "PERSON" shall mean an individual, corporation,
partnership, limited liability company, association, trust, joint venture,
unincorporated organization or any government, governmental department or
agency or political subdivision thereof.
11
<PAGE>
6.14 The term "PRICE REDUCTION" shall have the meaning ascribed
to it in Section 1.5 hereof.
6.15 The term "PURCHASE AND SALE AGREEMENT" shall mean that
certain Stock Purchase and Sale Agreement dated as of April 14, 1999 between
the Company and Holder.
6.16 The term "VOTING SECURITIES" shall mean stock of any class
or classes (or equivalent interests), if the holders of the stock of such
class or classes (or equivalent interests) are ordinarily, in the absence of
contingencies, entitled to vote for the election of the directors (or persons
performing similar functions) of such business entity, even though the right
so to vote has been suspended by the happening of such a contingency.
6.17 The term "WARRANT" shall refer to this or any replacement
Warrant covering any Warrant Shares.
6.18 The term "WARRANT SHARES" shall have the meaning ascribed
to it in the introductory paragraph to this Warrant, provided that such term
shall include all Other Securities issuable from time to time upon exercise
of this Warrant in whole or in part.
SECTION 7 REPLACEMENT OF WARRANTS.
Upon surrender of this Warrant in mutilated form or receipt of
evidence satisfactory to the Company of the loss, theft or destruction of
this Warrant, then, the Company, at the Holder's expense, shall execute and
deliver, in lieu of and in replacement of this Warrant, a Warrant identical
in form to this Warrant.
SECTION 8 REMEDIES.
The Company stipulates that the remedies at law of the Holder in the
event of any breach or threatened breach by the Company of the terms of this
Warrant are not and will not be adequate, and that such terms may be
specifically enforced by a decree for the specific performance of any
agreement contained herein or by an injunction against a breach of any of the
terms hereof or otherwise. The Company hereby irrevocably waives, to the
extent that it may do so under applicable law, any defense based on the
adequacy of a remedy at law which may be asserted as a bar to the remedy of
specific performance in any action brought against the Company for specific
performance of this Warrant by the Holder. Such remedies and all other
remedies provided for in this Warrant shall, however, be cumulative and not
exclusive and shall be in addition to any other remedies which may be
available under this Warrant.
SECTION 9 APPLICABILITY OF ARTICLE FIFTH OF CERTIFICATE OF
INCORPORATION; TRANSFER.
This Warrant and its direct and indirect owners are subject to all
of the restrictions set forth in Article Fifth of the Company's Certificate
of Incorporation and in Section 4.11(b) of the Purchase and Sale Agreement.
Upon a transfer in accordance with this Section 9, the Company at its expense
(excluding any applicable transfer taxes) shall execute and deliver, in lieu
of and in replacement of this Warrant, Warrants identical in form to this
Warrant and in such denominations as the transferring Holder shall request;
provided that, any such transferee, by
12
<PAGE>
acceptance hereof, agrees to assume all of the obligations of Holder and be
bound by all of the terms and provisions of this Warrant.
SECTION 10 NOTICES.
Where this Warrant provides for notice of any event, such notice
shall be given (unless otherwise herein expressly provided) in writing and
either (i) delivered personally, (ii) sent by certified, registered or
express mail or a nationally recognized express courier, postage and other
applicable charges prepaid, (iii) sent by facsimile transmission, and shall
be deemed given when so delivered personally, sent by facsimile transmission
(confirmed in writing) or four days after being mailed. Notices shall be
addressed, as follows:
if to Holder:
SZ Investments, L.L.C.
Two North Riverside Plaza
Suite 600
Chicago, IL 60606
Attention: Bill Pate
if to the Company:
Danielson Holding Corporation
767 Third Avenue
New York, NY 10017
Attention: General Counsel
provided, that the exercise of this Warrant shall be effective in the manner
provided in Section 1 hereof.
SECTION 11 SALE OF WARRANT OR SHARES.
Neither this Warrant nor the shares of Common Stock issuable upon
exercise hereof have been registered under the Securities Act of 1933, as
amended (the "Federal Act"), or under the securities laws of any state.
Neither this Warrant nor such shares, when issued, may be sold, transferred,
pledged or hypothecated in the absence of an effective registration statement
for this Warrant, or the shares, as the case may be, under the Federal Act,
such registration or qualification as may be necessary under the securities
laws of any state, an exemption from such registration or qualification
requirements. The certificate or certificates evidencing all or any of the
shares issued upon exercise of this Warrant shall bear the following legend:
"The securities represented by this certificate have not been
registered under the Securities Act of 1933, as amended, or any state
securities act and may not be sold or transferred in the absence of
such registration or an exemption therefrom, or in the absence of
receipt by the issuer of an opinion of counsel reasonably satisfactory
to the issuer that the securities may be sold or transferred without
such registration. The securities represented by this
13
<PAGE>
certificate are also subject to certain restrictions on transfer
contained in the issuer's Certificate of Incorporation."
This Warrant shall be registered on the books of the Company, which
shall be kept by it at its principal office for that purpose and shall be
transferable only on said books by the registered Holder's duly authorized
attorney upon surrender of this Warrant properly endorsed, and only in
compliance with the provisions of the preceding paragraph.
SECTION 12 NO DIVIDENDS OR VOTING RIGHTS.
No provision of this Warrant shall be construed as conferring upon
the Holder the right to receive dividends or to vote as a shareholder of the
Company, or as imposing any obligation on the Holder to purchase any
securities or as imposing any liabilities on such Holder as a stockholder of
the Company, whether such obligation or liabilities are asserted by the
Company or by creditors of the Company.
SECTION 13 MISCELLANEOUS.
This Warrant shall be binding upon the Company and Holder and their
legal representatives, successors and permitted assigns. In case any
provision of this Warrant shall be invalid, illegal or unenforceable, or
partially invalid, illegal or unenforceable, the provision shall be enforced
to the extent, if any, that it may legally be enforced and the validity,
legality and enforceability of the remaining provisions shall not in any way
be affected or impaired thereby. This Warrant and any term hereof may be
changed, waived, discharged or terminated only by a statement in writing
signed by the party against which enforcement of such change, waiver,
discharge or termination is sought. This Warrant shall be governed by, and
construed and enforced in accordance with, the laws of the State of Delaware
without regard to its principles of conflicts of laws. The headings in this
Warrant are for purposes of reference only, and shall not limit or otherwise
affect any of the terms hereof. This Warrant may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
constitute one and the same instrument.
SECTION 14 JUDICIAL PROCEEDINGS; WAIVER OF JURY TRIAL. Any judicial
proceeding brought against the Company with respect to this Warrant may be
brought in any state or federal court of competent jurisdiction in the State
of Delaware and, by execution and delivery of this Agreement, the Company (a)
accepts, generally and unconditionally, the nonexclusive jurisdiction of such
courts and any related appellate court, and irrevocably agrees to be bound by
any judgment rendered thereby in connection with this Warrant, subject to any
rights of appeal, and (b) irrevocably waives any objection the Company may
now or hereafter have as to the venue of any such suit, action or proceeding
brought in such a court or that such court is an inconvenient forum. THE
COMPANY HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING,
DIRECTLY, OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR
OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTION WITH THIS
WARRANT OR THE RELATIONSHIP ESTABLISHED HEREUNDER.
14
<PAGE>
IN WITNESS WHEREOF, the Company and the Holder have caused this
Warrant to be executed as an instrument under seal by a duly authorized
officer and, in the case of the Company, attested by its Secretary or
Assistant Secretary.
Dated as of August 12, 1999
(Corporate Seal)
DANIELSON HOLDING CORPORATION
Attest:
By:
- ----------------------------- -------------------------------------
Secretary/Assistant Secretary Name:
Title:
15
<PAGE>
EXHIBIT A
FORM OF SUBSCRIPTION
(To be signed only on exercise of Warrant)
TO: DANIELSON HOLDING CORPORATION
The undersigned, the holder of the within Warrant, hereby
irrevocably elects to exercise this Warrant for, and to receive thereunder,
shares of Common Stock of DANIELSON HOLDING CORPORATION (the "Company"), and
herewith makes payment of $_________ therefor, and requests that the
certificates (or escrow receipts therefor, in lieu thereof, if applicable)
for such shares be issued in the name of _________________________, and
delivered to _________________________ whose address is
_____________________________________________________________.
Dated:
------------------------------
------------------------------
(Signature must conform in all
respects to name of Holder as
specified on the face of the Warrant)
-------------------------------------
(Address)
- ----------------
*Insert here the number of shares of Common Stock to which the Warrant is being
exercised (including partial exercise), and in any event without making any
adjustment for Additional Shares of Common Stock or any other stock or Other
Securities or property or cash which, pursuant to the adjustment provisions of
this Warrant, may be delivered upon exercise. In the case of partial exercise, a
new Warrant or Warrants will be issued and delivered, representing the
unexercised portion of the Warrant, to the holder of the surrendering Warrant.
<PAGE>
EXHIBIT B
FORM OF NOTICE OF CONVERSION
(To be executed upon conversion of Warrant)
The undersigned hereby irrevocably elects to exercise the right,
represented by the Warrant delivered herewith, in accordance with Section 1.2
of the Warrant, to convert the Warrant represented thereby into ___ shares of
Common Stock in accordance with the terms hereof. The undersigned requests
that a certificate (or escrow receipts therefor, in lieu thereof, if
applicable) for such shares of Common Stock be registered in the name of
___________________________ whose address is _____________________________
and that such certificate be delivered to _______________________ whose
address is ___________________. If said number of shares of Common Stock is
less than all of the Warrant Shares obtainable hereunder, the undersigned
requests that a new Warrant representing the remaining balance of the Warrant
Shares be registered in the name of ___________________________ whose address
is ______________________________ and that such Warrant be delivered to
____________________________ whose address is ____________________________.
Signature:
- --------------------------------------------------
(Signature must conform in all respects to name
of Holder as specified on the face of the Warrant.)
Date:
--------------
